Notice Pursuant to the National Cooperative Research and Production Act of 1993-UHD Alliance, Inc., 31069-31070 [2017-14073]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 127 / Wednesday, July 5, 2017 / Notices
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All such requests
should be directed to the Secretary to
the Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: June 29, 2017.
Lisa R. Barton,
Secretary to the Commission.
BILLING CODE ;P
DEPARTMENT OF JUSTICE
BILLING CODE 7020–02–P
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Vehicle Safety
Communications 6 Consortium
DEPARTMENT OF JUSTICE
Antitrust Division
sradovich on DSK3GMQ082PROD with NOTICES
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Vehicle Safety
Communications 7 Consortium
Notice is hereby given that, on May
31, 2017, pursuant to Section 6(a) of the
National Cooperative Research and
2 All contract personnel will sign appropriate
nondisclosure agreements.
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
17:57 Jul 03, 2017
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2017–14071 Filed 7–3–17; 8:45 am]
[FR Doc. 2017–14041 Filed 7–3–17; 8:45 am]
VerDate Sep<11>2014
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Vehicle Safety
Communications 7 Consortium (‘‘VSC7
Consortium’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing (1) the identities
of the parties to the venture and (2) the
nature and objectives of the venture.
The notifications were filed for the
purpose of invoking the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances.
Pursuant to Section 6(b) of the Act,
the identities of the parties to the
venture are: General Motors Holdings
LLC, Warren, MI; Ford Motor Company,
Dearborn, MI; Honda R&D Americas,
Inc., Torrance, CA; Hyundia-Kia
America Technical Center, Inc.,
Superior Township, MI; Mazda Motor of
America, Inc., Farmington Hills, MI;
Nissan Technical Center North America,
Farmington Hills, MI; Toyota Motor
Engineering & Manufacturing North
America, Plano, TX; and Volkswagen/
Audi of America, Auburn Hills, MI. The
general area of VSC7 Consortium’s
planned activity is collaboration to
conduct or facilitate cooperative
research, development, testing, and
evaluation procedures to gain further
knowledge and understanding of a
security credential management system
for use in a connected vehicle
environment. VSC7 Consortium’s
objectives are to promote the interests of
the automotive sector while maintaining
impartiality, the independence of its
members, and vendor neutrality.
Jkt 241001
Notice is hereby given that, on May
31, 2017, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Vehicle Safety
Communications 6 Consortium (‘‘VSC6
Consortium’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing (1) the identities
of the parties to the venture and (2) the
nature and objectives of the venture.
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
31069
The notifications were filed for the
purpose of invoking the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances.
Pursuant to Section 6(b) of the Act,
the identities of the parties to the
venture are: General Motors Holdings
LLC, Warren, MI; Ford Motor Company,
Dearborn, MI; Honda R&D Americas,
Inc., Torrance, CA; Hyundia-Kia
America Technical Center, Inc.,
Superior Township, MI; Nissan
Technical Center North America,
Farmington Hills, MI; and Volkswagen/
Audi of America, Auburn Hills, MI.
The general area of VSC6
Consortium’s planned activity is
collaboration to conduct or facilitate
cooperative research, development,
testing, and evaluation procedures to
gain further knowledge and
understanding of connected vehicle
interactions and/or applications for
vehicles that are intended to transform
surface transportation safety, mobility,
and environmental performance through
a connected vehicle environment. VSC6
Consortium’s objectives are to promote
the interests of the automotive sector
while maintaining impartiality, the
independence of its members, and
vendor neutrality.
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2017–14074 Filed 7–3–17; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—UHD Alliance, Inc.
Notice is hereby given that, on June 6,
2017, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C.
§ 4301 et seq. (‘‘the Act’’), UHD
Alliance, Inc. (‘‘UHD Alliance’’) filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
changes in its membership. The
notifications were filed for the purpose
of extending the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances. Specifically,
HP Inc., Houston, TX, and Tata Sky
Limited, Mumbai, INDIA, have been
added as parties to this venture. Also,
The DIRECTV Group, Inc., El Segundo,
CA; Arcelik AS Electronics Plant,
Istanbul, TURKEY; DreamWorks
E:\FR\FM\05JYN1.SGM
05JYN1
31070
Federal Register / Vol. 82, No. 127 / Wednesday, July 5, 2017 / Notices
Animation L.L.C., Glendale, CA;
Microsoft Corporation, Redmond, WA;
Tongfang Global, Ltd. (Seiki), Diamond
Bar, CA; and Walt Disney Pictures,
Burbank, CA, have been dropped as
parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and UHD Alliance
intends to file additional written
notifications disclosing all changes in
membership.
On June 17, 2015, UHD Alliance filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on July 17, 2015 (80 FR
42537).
The last notification was filed with
the Department on March 9, 2017. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on April 10, 2017 (82 FR 17280).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2017–14073 Filed 7–3–17; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 16–31]
Phong Tran, M.D.; Decision and Order
sradovich on DSK3GMQ082PROD with NOTICES
On June 29, 2016, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration (hereinafter, DEA or
Government), issued an Order to Show
Cause to Phong Tran, M.D. (hereinafter,
Respondent), the holder of 19
Certificates of Registration.1 Order to
1 The 19 Certificates of Registration referenced in
the Order to Show Cause are: FT4325242 in Vista,
California (expiration date: November 30, 2016);
FT4123422 in Garden Grove, California (expiration
date: November 30, 2016); FT4086888 in Chula
Vista, California (expiration date: November 30,
2016); FT4086876 in Escondido, California
(expiration date: November 30, 2016); FT4086698 in
San Diego, California (expiration date: November
30, 2016); FT4086686 in San Bernardino, California
(expiration date: November 30, 2016); FP4086864 in
Long Beach, California (expiration date: November
30, 2016); FT4046707 in Van Nuys, California
(expiration date: November 30, 2018); FT3965540 in
Anaheim, California (expiration date: November 30,
2018); FT4046543 in Temecula, California
(expiration date: November 30, 2018); BT3239945
in Westminster, California (expiration date:
November 30, 2018); FT4083111 in Downey,
California (expiration date: November 30, 2016);
FT4932097 in Rialto, California (expiration date:
November 30, 2017); FT4946957 in Indio, California
(expiration date: November 30, 2017); FT4946971 in
Palmdale, California (expiration date: November 30,
VerDate Sep<11>2014
17:57 Jul 03, 2017
Jkt 241001
Show Cause, at 1–3. Citing 21 U.S.C.
823(f) and 824(a)(3), the Show Cause
Order proposed the revocation of
Respondent’s 19 Certificates of
Registration on the ground that
Respondent does not have authority to
dispense controlled substances in the
State of California, the State in which he
is registered. Id. at 4.
As the jurisdictional basis for the
proceeding, the Show Cause Order
alleged that each of Respondent’s 19
Certificates of Registration ‘‘are current
and unexpired.’’ Order to Show Cause,
at 4. Respondent’s registrations
authorize him to dispense controlled
substances in Schedules II through V.
Government’s Motion for Summary
Disposition, Attachment 1, at 5–23.
As the substantive grounds for the
proceeding, the Show Cause Order
alleged that on or about December 9,
2015, Respondent was criminally
charged in the County of San Diego
Superior Court (hereinafter, Superior
Court) with 45 counts related to
unlawful billing under the California
Workers’ Compensation System and that
the charges were pending resolution. Id.
at 4. The Show Cause Order further
alleged that, in response to the criminal
charges, the Medical Board of California
(hereinafter, MBC) petitioned the
Superior Court for an order suspending
Respondent’s medical license during the
pendency of the criminal proceedings.
Id. The Show Cause Order alleged that,
on May 13, 2016, the Superior Court
issued an Order granting the MBC’s
petition ‘‘and thereby . . . indefinitely
suspended . . . [Respondent’s]
California medical license effective June
3, 2016.’’ Id. The Order to Show Cause
alleged that Respondent’s medical
license remained suspended and,
‘‘therefore, DEA must revoke . . .
[Respondent’s] DEA . . . [registrations]
based upon . . . [his] lack of authority
to handle controlled substances in the
State of California.’’ Id. (citing 21 U.S.C.
802(21), 823(f)(1), and 824(a)(3)).
The Show Cause Order notified
Respondent of his right to request a
hearing on the allegations or to submit
a written statement while waiving his
right to a hearing, the procedure for
electing either option, and the
consequences for failing to elect either
option. Id. at 4–5 (citing 21 CFR
1301.43). It also notified Respondent of
his right to submit a corrective action
2017); FT4963117 in Pasadena, California
(expiration date: November 30, 2017); FT4963129 in
Pomona, California (expiration date: November 30,
2017); FT4963131 in Hemet, California (expiration
date: November 30, 2017); and FT3933593 in San
Bernardino, California (expiration date: November
30, 2018). Order to Show Cause, at 1–3.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
plan. Id. at 5 (citing 21 U.S.C.
824(c)(2)(C)).
By letter dated August 25, 2016,
Respondent requested a hearing stating
that ‘‘Dr. Tran’s medical license is still
active and valid, and not suspended as
alleged.’’ Hearing Request (August 25,
2016), at 1.
On August 29, 2016, Chief
Administrative Law Judge John J.
Mulrooney, II (hereinafter, CALJ) issued
an order setting September 9, 2016 as
the date for the Government to submit
evidence supporting the lack of state
authority allegation and for any party’s
motion for summary disposition to be
due. Order Directing the Filing of Proof
of Service, Evidence of Lack of State
Authority Allegation, and Briefing
Schedule, at 2.2
On September 9, 2016, the
Government filed its proof of service
evidence and Motion for Summary
Disposition. Government’s Proof of
Service Evidence and Motion for
Summary Disposition (hereinafter,
Government’s Motion). The
Government’s Motion argued that
Respondent was ‘‘without state
authorization to handle controlled
substances in California, and as [sic]
result, is not entitled to maintain his
DEA Certificates of Registration.’’ Id. at
1.
As support for its Motion, the
Government provided a sworn
Certification by the Chief of DEA’s
Registration and Program Support
Section concerning each of
Respondent’s DEA registrations in
California. Government’s Motion, at
Attachment 1 (Certification of
Registration History dated June 29,
2016). The Certification attached a copy
of each of Respondent’s DEA
registrations. Id. at 5–23. The
Government also provided the MBC’s
Notice ‘‘to recommend that the
[Superior] Court issue an Order
prohibiting . . . Phong Hung Tran, M.D.
. . . from practicing or attempting to
practice medicine as a physician in the
State of California, as a condition of any
bail or own recognizance release, during
the pendency of . . . criminal
proceedings.’’ Government’s Motion, at
Attachment 2 (Notice of PC23
Appearance and Recommendation at
PC1275 Bail Hearing dated April 12,
2016) (hereinafter, MBC Notice), at 2.
The Government’s Motion also attached
the MBC’s brief in support of the MBC
Notice. Government’s Motion, at
Attachment 3 (Memorandum in Support
of Penal Code Section 23 Appearance
2 The Order also set the date and time for the
Government to furnish proof of when it served the
Order to Show Cause on Respondent. Id. at 1.
E:\FR\FM\05JYN1.SGM
05JYN1
]]>Agencies
[Federal Register Volume 82, Number 127 (Wednesday, July 5, 2017)]
[Notices]
[Pages 31069-31070]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-14073]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--UHD Alliance, Inc.
Notice is hereby given that, on June 6, 2017, pursuant to Section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. Sec. 4301 et seq. (``the Act''), UHD Alliance, Inc. (``UHD
Alliance'') filed written notifications simultaneously with the
Attorney General and the Federal Trade Commission disclosing changes in
its membership. The notifications were filed for the purpose of
extending the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Specifically, HP Inc., Houston, TX, and Tata Sky Limited, Mumbai,
INDIA, have been added as parties to this venture. Also, The DIRECTV
Group, Inc., El Segundo, CA; Arcelik AS Electronics Plant, Istanbul,
TURKEY; DreamWorks
[[Page 31070]]
Animation L.L.C., Glendale, CA; Microsoft Corporation, Redmond, WA;
Tongfang Global, Ltd. (Seiki), Diamond Bar, CA; and Walt Disney
Pictures, Burbank, CA, have been dropped as parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and UHD Alliance intends to file
additional written notifications disclosing all changes in membership.
On June 17, 2015, UHD Alliance filed its original notification
pursuant to Section 6(a) of the Act. The Department of Justice
published a notice in the Federal Register pursuant to Section 6(b) of
the Act on July 17, 2015 (80 FR 42537).
The last notification was filed with the Department on March 9,
2017. A notice was published in the Federal Register pursuant to
Section 6(b) of the Act on April 10, 2017 (82 FR 17280).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2017-14073 Filed 7-3-17; 8:45 am]
BILLING CODE P
